MYELODYSPLASTIC SYNDROMES (MDS)
Clinical trials for MYELODYSPLASTIC SYNDROMES (MDS) explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROMES (MDS) trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROMES (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a common diabetes drug fix MDS anemia?
Disease control Not yet recruitingThis phase II trial tests whether dapagliflozin, a drug used for diabetes, can improve anemia in people with lower-risk myelodysplastic syndromes (MDS). Anemia is a major problem in MDS, causing fatigue and often requiring blood transfusions. The study will give 37 participants d…
Matched conditions: MYELODYSPLASTIC SYNDROMES (MDS)
Phase: PHASE2 • Sponsor: Seug yun Yoon, MD • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
New study aims to cut relapse in tough blood cancers after transplant
Disease control Not yet recruitingThis study compares two methods of giving donor immune cells (donor lymphocyte infusion) after a stem cell transplant to prevent cancer from coming back in people with hard-to-treat acute myeloid leukemia or myelodysplastic syndromes. About 200 participants will be randomly assig…
Matched conditions: MYELODYSPLASTIC SYNDROMES (MDS)
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC
-
New registry to map MDS in asia: no treatment, just data
Knowledge-focused Not yet recruitingThis study is a registry that will collect information from about 500 adults in Asia who have been diagnosed with myelodysplastic syndromes (MDS). Researchers will look at patient details like age, sex, medical history, lab results, and treatments received. The goal is to better …
Matched conditions: MYELODYSPLASTIC SYNDROMES (MDS)
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:05 UTC